Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

The ICER Process: Allergan Engagement Improves Cost Effectiveness Rating For Ubrelvy

Jan 27 2020

• By Cathy Kelly

3d illustration of Man suffering migraine — Valuing Drugs For Acute Migraine

Related Companies

Allergan plc

Biohaven Pharmaceutical Holding Company Ltd.

Eli Lilly and Company

Additional Topics

United States Pricing Strategies Reimbursement Health Technology Assessment Policy BioPharmaceutical

More from Drug Pricing

More from Scrip

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.